In conclusion, we propose that gefitinib radiosensitizes NSCLC cells through inhibiting IR-induced ATM activation, and therefore acts as a G2 checkpoint inhibitor to induce mitotic catastrophic cell death. This evidence concerns the gene ATM and non-small cell lung carcinoma.